[Dosage of antithrombin III in women taking oral contraceptives]. 1980

N Agoumi, and C Messerschmitt, and C Nejjar, and V L Guon

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003276 Contraceptives, Oral Compounds, usually hormonal, taken orally in order to block ovulation and prevent the occurrence of pregnancy. The hormones are generally estrogen or progesterone or both. Low-Dose Oral Contraceptive,Oral Contraceptive,Oral Contraceptives,Oral Contraceptives, Low-Dose,Oral Contraceptives, Phasic,Contraceptive, Low-Dose Oral,Contraceptive, Oral,Contraceptives, Low-Dose Oral,Contraceptives, Phasic Oral,Low Dose Oral Contraceptive,Low-Dose Oral Contraceptives,Oral Contraceptive, Low-Dose,Oral Contraceptives, Low Dose,Phasic Oral Contraceptives
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000990 Antithrombin III A plasma alpha 2 glycoprotein that accounts for the major antithrombin activity of normal plasma and also inhibits several other enzymes. It is a member of the serpin superfamily. Heparin Cofactor I,Antithrombin III-Alpha,Atenativ,Heparin Co-Factor I,Kybernin,Serpin C1,Thrombate III,Antithrombin III Alpha,Antithrombin IIIAlpha,Cofactor I, Heparin,Heparin Co Factor I

Related Publications

N Agoumi, and C Messerschmitt, and C Nejjar, and V L Guon
February 1979, La Nouvelle presse medicale,
N Agoumi, and C Messerschmitt, and C Nejjar, and V L Guon
November 1985, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
N Agoumi, and C Messerschmitt, and C Nejjar, and V L Guon
June 1991, American journal of obstetrics and gynecology,
N Agoumi, and C Messerschmitt, and C Nejjar, and V L Guon
March 1971, American journal of obstetrics and gynecology,
N Agoumi, and C Messerschmitt, and C Nejjar, and V L Guon
January 1981, Thrombosis research,
N Agoumi, and C Messerschmitt, and C Nejjar, and V L Guon
March 1979, American journal of clinical pathology,
N Agoumi, and C Messerschmitt, and C Nejjar, and V L Guon
July 1979, American journal of clinical pathology,
N Agoumi, and C Messerschmitt, and C Nejjar, and V L Guon
January 1974, Acta physiologica Academiae Scientiarum Hungaricae,
N Agoumi, and C Messerschmitt, and C Nejjar, and V L Guon
January 1974, Pathologie-biologie,
N Agoumi, and C Messerschmitt, and C Nejjar, and V L Guon
May 1970, Lancet (London, England),
Copied contents to your clipboard!